{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T17:14:58Z","timestamp":1773249298129,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,5]],"date-time":"2020-09-05T00:00:00Z","timestamp":1599264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,5]],"date-time":"2020-09-05T00:00:00Z","timestamp":1599264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Technology Innovation Project of Science and Technology Bureau of Chengdu","award":["2018-YF05-00247-SN"],"award-info":[{"award-number":["2018-YF05-00247-SN"]}]},{"name":"the Scientific Research Project of Sichuan Medical Association","award":["S17060"],"award-info":[{"award-number":["S17060"]}]},{"name":"the Science and Technology Innovation Fund of Sichuan Provincial Hospital for Women and Children","award":["20180205"],"award-info":[{"award-number":["20180205"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Biol Endocrinol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Oxidative stress (OS), defined as an imbalance between excessive reactive oxygen species (ROS) and\/or reactive nitrogen species (RNS) production and antioxidant insufficiency, has been suggested to be involved in the pathogenesis of poor ovarian response (POR). Growth hormone (GH) can reduce OS in some cell types. This study investigated whether GH can improve OS and the in vitro fertilization and embryo transfer (IVF-ET) outcomes of poor ovarian responders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study enrolled 105 patients with POR and 58 patients without POR (controls) who were diagnosed according to the Bologna criteria and underwent conventional IVF-ET. Poor ovarian responders were randomly assigned to two groups: the POR-GH group, which received pretreatment with GH 4\u2009IU\/d on day 2 of the previous menstrual cycle before IVF until the trigger day, and the POR-C group, which received no pretreatment. OS markers in follicular fluid (FF), ROS levels in granulosa cells (GCs), and the IVF outcomes of the groups were compared.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Endometrial thickness on trigger day, the number of cleaved embryos, the number of higher-quality embryos, and the rates of embryo formation, higher-quality embryo formation, implantation and clinical pregnancy were significantly increased in the POR-GH group compared with the POR-C group (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05). Moreover, compared to those in the non-POR group, FF malondialdehyde (MDA), total oxidant status (TOS), oxidative stress index (OSI) and ROS levels in GCs were significantly higher, whereas superoxide dismutase (SOD) and the total antioxidant capacity (TAC) were significantly lower in the POR-C group (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05). Furthermore, compared with those in the POR-C group, the FF TAC was significantly increased in the POR-GH group, and TOS, OSI and intracellular ROS levels were significantly reduced (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Pretreatment with GH alleviates OS and improves oocyte quality and IVF outcomes of poor ovarian responders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      Chinese Clinical Trial Registry.\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.chictr.org.cn\/index.aspx\">ChiCTR1900021269<\/jats:ext-link>\n                      . Registered 8 February 2019,\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.chictr.org.cn\/edit.aspx?pid=35837&amp;htm=4\">http:\/\/www.chictr.org.cn\/edit.aspx?pid=35837&amp;htm=4<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12958-020-00648-2","type":"journal-article","created":{"date-parts":[[2020,9,5]],"date-time":"2020-09-05T04:03:22Z","timestamp":1599278602000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Growth hormone alleviates oxidative stress and improves the IVF outcomes of poor ovarian responders: a randomized controlled trial"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3562-971X","authenticated-orcid":false,"given":"Yan","family":"Gong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongsheng","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiajing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengfang","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,5]]},"reference":[{"key":"648_CR1","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1093\/humrep\/der092","volume":"26","author":"AP Ferraretti","year":"2011","unstructured":"Ferraretti AP, La Marca a, Fauser BC, Tarlatzis B, Nargund G, Gianaroli L. Definition EwgoPOR. ESHRE consensus on the definition of \u2018poor response\u2019 to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod. 2011;26:1616\u201324.","journal-title":"Hum Reprod"},{"key":"648_CR2","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1093\/humupd\/dmp026","volume":"15","author":"EM Kolibianakis","year":"2009","unstructured":"Kolibianakis EM, Venetis CA, Diedrich K, Tarlatzis BC, Griesinger G. Addition of growth hormone to gonadotrophins in ovarian stimulation of poor responders treated by in-vitro fertilization: a systematic review and meta-analysis. Hum Reprod Update. 2009;15:613\u201322.","journal-title":"Hum Reprod Update"},{"key":"648_CR3","doi-asserted-by":"publisher","first-page":"70","DOI":"10.4103\/0974-1208.183515","volume":"9","author":"YB Jeve","year":"2016","unstructured":"Jeve YB, Bhandari HM. Effective treatment protocol for poor ovarian response: a systematic review and meta-analysis. J Hum Reprod Sci. 2016;9:70\u201381.","journal-title":"J Hum Reprod Sci"},{"key":"648_CR4","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.fertnstert.2007.12.077","volume":"91","author":"D Kyrou","year":"2009","unstructured":"Kyrou D, Kolibianakis EM, Venetis CA, Papanikolaou EG, Bontis J, Tarlatzis BC. How to improve the probability of pregnancy in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis. Fertil Steril. 2009;91:749\u201366.","journal-title":"Fertil Steril"},{"key":"648_CR5","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1387\/ijdb.120141ue","volume":"56","author":"U Eichenlaub-Ritter","year":"2012","unstructured":"Eichenlaub-Ritter U. Oocyte ageing and its cellular basis. Int J Dev Biol. 2012;56:841\u201352.","journal-title":"Int J Dev Biol"},{"key":"648_CR6","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1093\/humupd\/dmm048","volume":"14","author":"C Tatone","year":"2008","unstructured":"Tatone C, Amicarelli F, Carbone MC, Monteleone P, Caserta D, Marci R, et al. Cellular and molecular aspects of ovarian follicle ageing. Hum Reprod Update. 2008;14:131\u201342.","journal-title":"Hum Reprod Update"},{"key":"648_CR7","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12958-016-0184-7","volume":"14","author":"A Luddi","year":"2016","unstructured":"Luddi A, Capaldo A, Focarelli R, Gori M, Morgante G, Piomboni P, et al. Antioxidants reduce oxidative stress in follicular fluid of aged women undergoing IVF. Reprod Biol Endocrinol. 2016;14:57.","journal-title":"Reprod Biol Endocrinol"},{"key":"648_CR8","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1093\/humupd\/dms059","volume":"19","author":"M Murri","year":"2013","unstructured":"Murri M, Luque-Ramirez M, Insenser M, Ojeda-Ojeda M, Escobar-Morreale HF. Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis. Hum Reprod Update. 2013;19:268\u201388.","journal-title":"Hum Reprod Update"},{"key":"648_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/biof.5520270101","volume":"27","author":"OI Aruoma","year":"2006","unstructured":"Aruoma OI, Grootveld M, Bahorun T. Free radicals in biology and medicine: from inflammation to biotechnology. Biofactors. 2006;27:1\u20133.","journal-title":"Biofactors."},{"key":"648_CR10","doi-asserted-by":"publisher","first-page":"R18","DOI":"10.1152\/ajpregu.00327.2006","volume":"292","author":"KC Kregel","year":"2007","unstructured":"Kregel KC, Zhang HJ. An integrated view of oxidative stress in aging: basic mechanisms, functional effects, and pathological considerations. Am J Physiol Regul Integr Comp Physiol. 2007;292:R18\u201336.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"648_CR11","doi-asserted-by":"crossref","unstructured":"Hull KL, Harvey S. Growth hormone and reproduction: a review of endocrine and autocrine\/paracrine interactions. Int J Endocrinol 2014, 2014:234014.","DOI":"10.1155\/2014\/234014"},{"key":"648_CR12","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/1477-7827-7-101","volume":"7","author":"C Alviggi","year":"2009","unstructured":"Alviggi C, Humaidan P, Howles CM, Tredway D, Hillier SG. Biological versus chronological ovarian age: implications for assisted reproductive technology. Reprod Biol Endocrinol. 2009;7:101.","journal-title":"Reprod Biol Endocrinol"},{"key":"648_CR13","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1530\/REP-14-0494","volume":"149","author":"BM Weall","year":"2015","unstructured":"Weall BM, Al-Samerria S, Conceicao J, Yovich JL, Almahbobi G. A direct action for GH in improvement of oocyte quality in poor-responder patients. Reproduction. 2015;149:147\u201354.","journal-title":"Reproduction."},{"key":"648_CR14","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1507\/endocrj.EJ17-0330","volume":"65","author":"K Suzuki","year":"2018","unstructured":"Suzuki K, Yanagi K, Shimizu M, Wakamatsu S, Niitani T, Hosonuma S, et al. Effect of growth hormone replacement therapy on plasma diacron-reactive oxygen metabolites and endothelial function in Japanese patients: the GREAT clinical study. Endocr J. 2018;65:101\u201311.","journal-title":"Endocr J"},{"key":"648_CR15","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1093\/gerona\/glt187","volume":"69","author":"T Brioche","year":"2014","unstructured":"Brioche T, Kireev RA, Cuesta S, Gratas-Delamarche A, Tresguerres JA, Gomez-Cabrera MC, et al. Growth hormone replacement therapy prevents sarcopenia by a dual mechanism: improvement of protein balance and of antioxidant defenses. J Gerontol A Biol Sci Med Sci. 2014;69:1186\u201398.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"648_CR16","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1253\/circj.CJ-09-0378","volume":"74","author":"Y Kato","year":"2010","unstructured":"Kato Y, Iwase M, Ichihara S, Kanazawa H, Hashimoto K, Noda A, et al. Beneficial effects of growth hormone-releasing peptide on myocardial oxidative stress and left ventricular dysfunction in dilated cardiomyopathic hamsters. Circ J. 2010;74:163\u201370.","journal-title":"Circ J"},{"key":"648_CR17","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/nrm3531","volume":"14","author":"R Li","year":"2013","unstructured":"Li R, Albertini DF. The road to maturation: somatic cell interaction and self-organization of the mammalian oocyte. Nat Rev Mol Cell Biol. 2013;14:141\u201352.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"648_CR18","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/S0015-0282(99)00442-2","volume":"72","author":"G Barroso","year":"1999","unstructured":"Barroso G, Barrionuevo M, Rao P, Graham L, Danforth D, Huey S, et al. Vascular endothelial growth factor, nitric oxide, and leptin follicular fluid levels correlate negatively with embryo quality in IVF patients. Fertil Steril. 1999;72:1024\u20136.","journal-title":"Fertil Steril"},{"key":"648_CR19","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1093\/humrep\/der037","volume":"26","author":"Alpha Scientists in Reproductive M","year":"2011","unstructured":"Alpha Scientists in Reproductive M, Embryology ESIGo. The Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting. Hum Reprod. 2011;26:1270\u201383.","journal-title":"Hum Reprod"},{"key":"648_CR20","doi-asserted-by":"publisher","first-page":"e209","DOI":"10.1016\/j.fertnstert.2019.08.094","volume":"112","author":"D Navot","year":"2019","unstructured":"Navot D, Bergh PA, Laufer N. Reprint of: ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment. Fertil Steril. 2019;112:e209\u201321.","journal-title":"Fertil Steril"},{"key":"648_CR21","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3109\/09513590.2015.1075501","volume":"32","author":"S Yang","year":"2016","unstructured":"Yang S, Wang Q, Huang W, Song Y, Feng G, Zhou L, et al. Are serum chemerin levels different between obese and non-obese polycystic ovary syndrome women? Gynecol Endocrinol. 2016;32:38\u201341.","journal-title":"Gynecol Endocrinol"},{"key":"648_CR22","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/cen.13171","volume":"86","author":"R Zhang","year":"2017","unstructured":"Zhang R, Liu H, Bai H, Zhang Y, Liu Q, Guan L, et al. Oxidative stress status in Chinese women with different clinical phenotypes of polycystic ovary syndrome. Clin Endocrinol. 2017;86:88\u201396.","journal-title":"Clin Endocrinol"},{"key":"648_CR23","doi-asserted-by":"crossref","unstructured":"Zhou M, Liu XH, Liu QQ, Chen M, Bai H, Guan LB, et al. Lactonase activity, status, and genetic variations of Paraoxonase 1 in women with gestational diabetes mellitus. J Diabetes Res 2020, 2020:3483427.","DOI":"10.1155\/2020\/3483427"},{"key":"648_CR24","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/j.fertnstert.2011.09.032","volume":"96","author":"VY Fujimoto","year":"2011","unstructured":"Fujimoto VY, Bloom MS, Huddleston HG, Shelley WB, Ocque AJ, Browne RW. Correlations of follicular fluid oxidative stress biomarkers and enzyme activities with embryo morphology parameters during in vitro fertilization. Fertil Steril. 2011;96:1357\u201361.","journal-title":"Fertil Steril"},{"key":"648_CR25","doi-asserted-by":"publisher","first-page":"149","DOI":"10.21873\/invivo.11018","volume":"30","author":"C Siristatidis","year":"2016","unstructured":"Siristatidis C, Vogiatzi P, Varounis C, Askoxylaki M, Chrelias C, Papantoniou N. The effect of reactive oxygen species on embryo quality in IVF. Vivo. 2016;30:149\u201353.","journal-title":"Vivo"},{"key":"648_CR26","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1179\/135100009X12525712409418","volume":"14","author":"OA Oyawoye","year":"2009","unstructured":"Oyawoye OA, Abdel-Gadir A, Garner A, Leonard AJ, Perrett C, Hardiman P. The interaction between follicular fluid total antioxidant capacity, infertility and early reproductive outcomes during in vitro fertilization. Redox Rep. 2009;14:205\u201313.","journal-title":"Redox Rep"},{"key":"648_CR27","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1093\/humrep\/deu238","volume":"29","author":"E Scalici","year":"2014","unstructured":"Scalici E, Traver S, Molinari N, Mullet T, Monforte M, Vintejoux E, et al. Cell-free DNA in human follicular fluid as a biomarker of embryo quality. Hum Reprod. 2014;29:2661\u20139.","journal-title":"Hum Reprod"},{"key":"648_CR28","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.fertnstert.2013.01.129","volume":"99","author":"A Uyar","year":"2013","unstructured":"Uyar A, Torrealday S, Seli E. Cumulus and granulosa cell markers of oocyte and embryo quality. Fertil Steril. 2013;99:979\u201397.","journal-title":"Fertil Steril"},{"key":"648_CR29","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1093\/oxfordjournals.humrep.a138602","volume":"9","author":"EY Adashi","year":"1994","unstructured":"Adashi EY. Endocrinology of the ovary. Hum Reprod. 1994;9:815\u201327.","journal-title":"Hum Reprod"},{"key":"648_CR30","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1093\/molehr\/gag090","volume":"9","author":"MC Carbone","year":"2003","unstructured":"Carbone MC, Tatone C, Delle Monache S, Marci R, Caserta D, Colonna R, et al. Antioxidant enzymatic defences in human follicular fluid: characterization and age-dependent changes. Mol Hum Reprod. 2003;9:639\u201343.","journal-title":"Mol Hum Reprod"},{"key":"648_CR31","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/j.fertnstert.2009.05.028","volume":"94","author":"I Aurrekoetxea","year":"2010","unstructured":"Aurrekoetxea I, Ruiz-Sanz JI, del Agua AR, Navarro R, Hernandez ML, Matorras R, et al. Serum oxidizability and antioxidant status in patients undergoing in vitro fertilization. Fertil Steril. 2010;94:1279\u201386.","journal-title":"Fertil Steril"},{"key":"648_CR32","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/1477-7827-10-49","volume":"10","author":"A Agarwal","year":"2012","unstructured":"Agarwal A, Aponte-Mellado A, Premkumar BJ, Shaman A, Gupta S. The effects of oxidative stress on female reproduction: a review. Reprod Biol Endocrinol. 2012;10:49.","journal-title":"Reprod Biol Endocrinol"},{"key":"648_CR33","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1093\/humrep\/dei066","volume":"20","author":"J Tesarik","year":"2005","unstructured":"Tesarik J, Hazout A, Mendoza C. Improvement of delivery and live birth rates after ICSI in women aged >40 years by ovarian co-stimulation with growth hormone. Hum Reprod. 2005;20:2536\u201341.","journal-title":"Hum Reprod"},{"key":"648_CR34","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/0002-9378(95)90346-1","volume":"173","author":"FI Sharara","year":"1995","unstructured":"Sharara FI, Nieman LK. Growth hormone receptor messenger ribonucleic acid expression in leiomyoma and surrounding myometrium. Am J Obstet Gynecol. 1995;173:814\u20139.","journal-title":"Am J Obstet Gynecol"},{"key":"648_CR35","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ijgo.2015.10.020","volume":"133","author":"W Xue-Mei","year":"2016","unstructured":"Xue-Mei W, Hong J, Wen-Xiang Z, Yang L. The effects of growth hormone on clinical outcomes after frozen-thawed embryo transfer. Int J Gynaecol Obstet. 2016;133:347\u201350.","journal-title":"Int J Gynaecol Obstet"},{"key":"648_CR36","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s40618-018-0877-1","volume":"42","author":"N Cui","year":"2019","unstructured":"Cui N, Li AM, Luo ZY, Zhao ZM, Xu YM, Zhang J, et al. Effects of growth hormone on pregnancy rates of patients with thin endometrium. J Endocrinol Investig. 2019;42:27\u201335.","journal-title":"J Endocrinol Investig"},{"key":"648_CR37","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1007\/s00404-012-2655-1","volume":"287","author":"M Eftekhar","year":"2013","unstructured":"Eftekhar M, Aflatoonian A, Mohammadian F, Eftekhar T. Adjuvant growth hormone therapy in antagonist protocol in poor responders undergoing assisted reproductive technology. Arch Gynecol Obstet. 2013;287:1017\u201321.","journal-title":"Arch Gynecol Obstet"},{"key":"648_CR38","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.rbmo.2019.02.003","volume":"38","author":"RJ Norman","year":"2019","unstructured":"Norman RJ, Alvino H, Hull LM, Mol BW, Hart RJ, Kelly TL, et al. Human growth hormone for poor responders: a randomized placebo-controlled trial provides no evidence for improved live birth rate. Reprod BioMed Online. 2019;38:908\u201315.","journal-title":"Reprod BioMed Online"}],"container-title":["Reproductive Biology and Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-020-00648-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12958-020-00648-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-020-00648-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,4]],"date-time":"2021-09-04T19:21:37Z","timestamp":1630783297000},"score":1,"resource":{"primary":{"URL":"https:\/\/rbej.biomedcentral.com\/articles\/10.1186\/s12958-020-00648-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,5]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["648"],"URL":"https:\/\/doi.org\/10.1186\/s12958-020-00648-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-17445\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-17445\/v4","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-17445\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-17445\/v2","asserted-by":"object"}]},"ISSN":["1477-7827"],"issn-type":[{"value":"1477-7827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,5]]},"assertion":[{"value":"12 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Approval was obtained from the Medical Ethics Committee of Sichuan Provincial Hospital for Woman and Children. The procedures used in this study adhere to the tenets of the Declaration of Helsinki.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"91"}}